Oramed Pharmaceuticals
ORMP
#8980
Rank
S$0.17 B
Marketcap
S$4.35
Share price
0.29%
Change (1 day)
46.96%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): S$1.03

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$1.03. In 2024 the company made an earnings per share (EPS) of S-$0.61 a decrease over its 2023 EPS that were of S$0.18.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$1.03-268.79%
2024S-$0.61-442.86%
2023S$0.18-114.89%
2022S-$1.2020.51%
2021S-$0.9939.29%
2020S-$0.71-31.71%
2019S-$1.04-4.65%
2018S-$1.098.86%
2017S-$1.01-9.2%
2016S-$1.1129.85%
2015S-$0.858.06%
2014S-$0.795.08%
2013S-$0.753.51%
2012S-$0.73137.5%
2011S-$0.31-60%
2010S-$0.76-0%
2009S-$0.76-16.67%
2008S-$0.92-25%
2007S-$1.22700%
2006S-$0.15303.56%
2005S-$0.03785

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
S$4.47 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$4.72 357.49%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
S-$7.56-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S-$0.24-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S-$0.38-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel